| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |